RAB22A and cancer: In addition, the production of triple-negative breast cancer-derived ectosomes along with the growth and metastasis of cancer cells were significantly suppressed after Rab22a inhibition [132], highlighting the anti-cancer therapeutic potential of targeting ectosome formation.